Alas, this is the final post in the bronchiolitis series. I hope you've enjoyed it. Parts I, II, III, IV, V, VI, and VII aren't going anywhere - so check them out if you haven't done so yet. This post will focus on the disposition of patients with bronchiolitis in [...]
Welcome back to the seemingly endless spew of bronchiolitis related content here on the PEM Blog. Check out editions I, II, III, IV, V, and VI if you'd like. Today we'll be focusing on additional modes of respiratory support in babies with bronchiolitis. So, without further ado let's get to it. [...]
If you haven't read parts I, II, III, IV or V what are you waiting for? Today's post will focus on testing in bronchiolitis. And no, I won't be testing you... Let's get straight to the content. [divider scroll_text=""] Question: Do you need to get [...]
Parts I through IV are in the books, so let's move onto another therapy that has been tossed around as a potential solution to bronchiolitis - Corticosteroids. In the early 'aughts many of you may have given steroids to bronchiolitics, but now you don't. Perhaps it will [...]
Parts I, II, and III are still there for those of you yet to dive in but now we turn our attention to a lesser used, but potentially valuable therapy in bronchiolitis. ED providers are already familiar with its use in the management of elevated intracranial [...]
Though a meta-analysis shows that racemic epi may help on the initial visit, the AAP recommended that it not be used as a trial therapy for most outpatient providers in its latest clinical practice guideline. You'll see that my original post and recommendation aligns with what the AAP [...]
Though meta-analyses and systematic reviews - see below - have shown that beta agonists may improve symptoms scores they certainly don't affect disease resolution. Thus, since clinical scores are subjective and don't necessarily correlate with objective measurements. When sensitivity analysis is used to weed out [...]
According to the AAP's 2006 Clinical Practice Guideline, bronchiolitis is the most common lower respiratory tract infection (LRTI) in infants and is caused by a virus - most often RSV in 70-80%, Human metapneumovirus in 10-20%, and then assorted rogues such as Adenovirus, Rhinovirus, Parainfluenza, and [...]
Many of you may have come across the correspondance between BMJ and Roche already regarding Tamiflu. If not, take a moment to look it over, don't worry, I'll wait. http://www.bmj.com/tamiflu/roche OK, welcome back... Here's the bottom line - the flu vaccine is still available in [...]